home / stock / drrx / drrx quote
Last: | $1.21 |
---|---|
Change Percent: | 0.0% |
Open: | $1.25 |
Close: | $1.21 |
High: | $1.3 |
Low: | $1.17 |
Volume: | 234,260 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.21 | $1.25 | $1.21 | $1.3 | $1.17 | 234,260 | 03-29-2024 |
$1.21 | $1.25 | $1.21 | $1.3 | $1.17 | 234,251 | 03-28-2024 |
$1.34 | $1.27 | $1.34 | $1.34 | $1.2501 | 199,639 | 03-27-2024 |
$1.27 | $1.29 | $1.27 | $1.29 | $1.23 | 166,781 | 03-26-2024 |
$1.28 | $1.2 | $1.28 | $1.2895 | $1.2 | 85,576 | 03-25-2024 |
$1.17 | $1.26 | $1.17 | $1.28 | $1.15 | 121,787 | 03-22-2024 |
$1.25 | $1.25 | $1.25 | $1.28 | $1.18 | 87,627 | 03-21-2024 |
$1.28 | $1.18 | $1.28 | $1.31 | $1.165 | 91,483 | 03-20-2024 |
$1.18 | $1.32 | $1.18 | $1.35 | $1.18 | 156,426 | 03-19-2024 |
$1.35 | $1.27 | $1.35 | $1.38 | $1.27 | 106,679 | 03-18-2024 |
$1.29 | $1.39 | $1.29 | $1.44 | $1.23 | 212,951 | 03-15-2024 |
$1.37 | $1.15 | $1.37 | $1.4 | $1.1 | 423,415 | 03-14-2024 |
$1.13 | $1.14 | $1.13 | $1.199 | $1.08 | 121,584 | 03-13-2024 |
$1.15 | $1.01 | $1.15 | $1.18 | $1.01 | 318,410 | 03-12-2024 |
$1.01 | $1.02 | $1.01 | $1.02 | $1 | 84,933 | 03-11-2024 |
$1.01 | $0.99 | $1.01 | $1.02 | $0.99 | 117,608 | 03-08-2024 |
$0.98 | $0.99 | $0.98 | $1.01 | $0.9511 | 70,518 | 03-07-2024 |
$0.9777 | $0.95 | $0.9777 | $1.01 | $0.95 | 127,450 | 03-06-2024 |
$0.97 | $1.03 | $0.97 | $1.03 | $0.95 | 157,415 | 03-05-2024 |
$1.02 | $0.9686 | $1.02 | $1.05 | $0.94 | 853,083 | 03-04-2024 |
News, Short Squeeze, Breakout and More Instantly...
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update PR Newswire - Ongoing Communication with FDA to Align on Next Steps for Larsucosterol in Alcohol-Associated Hepatitis - Webcast of Earnings Call Today, M...
Cano Health Inc. Class A (CANOQ) is expected to report for Q4 2023 Cathay Pacific Airways Ltd. ADR (CPCAY) is expected to report for Q4 2023 NeuroSense Therapeutics Ltd. (NRSN) is expected to report for quarter end 2023-12-31 Bayerische Motoren Werke AG (BAMXF) is expected to report f...
DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update PR Newswire CUPERTINO, Calif. , March 20, 2024 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering th...